Home Cart 0 Sign in  
X

[ CAS No. 118289-16-0 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 118289-16-0
Chemical Structure| 118289-16-0
Chemical Structure| 118289-16-0
Structure of 118289-16-0 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 118289-16-0 ]

Related Doc. of [ 118289-16-0 ]

Alternatived Products of [ 118289-16-0 ]

Product Details of [ 118289-16-0 ]

CAS No. :118289-16-0 MDL No. :MFCD04039313
Formula : C6H6BrNO Boiling Point : -
Linear Structure Formula :- InChI Key :IQNUGAFIKDRYRP-UHFFFAOYSA-N
M.W : 188.02 Pubchem ID :14512957
Synonyms :

Calculated chemistry of [ 118289-16-0 ]

Physicochemical Properties

Num. heavy atoms : 9
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.17
Num. rotatable bonds : 1
Num. H-bond acceptors : 2.0
Num. H-bond donors : 1.0
Molar Refractivity : 38.06
TPSA : 33.12 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.74 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.5
Log Po/w (XLOGP3) : 0.99
Log Po/w (WLOGP) : 1.18
Log Po/w (MLOGP) : 0.65
Log Po/w (SILICOS-IT) : 1.89
Consensus Log Po/w : 1.24

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.06
Solubility : 1.65 mg/ml ; 0.00877 mol/l
Class : Soluble
Log S (Ali) : -1.27
Solubility : 10.0 mg/ml ; 0.0532 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.71
Solubility : 0.368 mg/ml ; 0.00196 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.62

Safety of [ 118289-16-0 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 118289-16-0 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 118289-16-0 ]
  • Downstream synthetic route of [ 118289-16-0 ]

[ 118289-16-0 ] Synthesis Path-Upstream   1~7

  • 1
  • [ 118289-16-0 ]
  • [ 118289-17-1 ]
Reference: [1] Chemical and Pharmaceutical Bulletin, 1990, vol. 38, # 9, p. 2446 - 2458
[2] Journal of Medicinal Chemistry, 2010, vol. 53, # 2, p. 822 - 839
[3] Patent: US2005/54654, 2005, A1, . Location in patent: Page/Page column 36
  • 2
  • [ 66572-56-3 ]
  • [ 118289-16-0 ]
YieldReaction ConditionsOperation in experiment
75.21% With boron trifluoride diethyl etherate In tetrahydrofuran at 0 - 20℃; for 3 h; To a solution of 215.1 (2g, 9.9mmol, l .Oeq) in tetrahydrofuran (30mL) at 0°C, boron trifluoride etherate (4.18g, 29.7mmol, 3.0eq) was added dropwise. Reaction mixture was stirred at room temperature for 3h. After completion of reaction, reaction mixture was transferred in ice-water and product was extracted with ethyl acetate. Organic layer was combined, washed with brine solution, dried over sodium sulphate and concentrated under reduced pressure to obtain 1.1 (1.4g, 75.21percent). MS(ES): m/z 189.65 [M]+
Reference: [1] Patent: WO2018/71794, 2018, A1, . Location in patent: Paragraph 00983; 00984
[2] Chemical and Pharmaceutical Bulletin, 1990, vol. 38, # 9, p. 2446 - 2458
[3] Journal of Medicinal Chemistry, 1997, vol. 40, # 18, p. 2866 - 2875
[4] Patent: US2005/54654, 2005, A1, . Location in patent: Page/Page column 36
[5] Patent: EP2098517, 2009, A1, . Location in patent: Page/Page column 32
  • 3
  • [ 118289-17-1 ]
  • [ 118289-16-0 ]
YieldReaction ConditionsOperation in experiment
90% With sodium tetrahydroborate In methanol at 0 - 20℃; for 1 h; Inert atmosphere To a solution of 2-bromopyridine-4-carbaldehyde (20 g, 107.52 mmol) in MeOH (150 mL) was added portion wise sodium borohydride (12.0 g, 322.56 mmol) at 0° C. under inert atmosphere.
The mixture was stirred at RT for 1 h.
Saturated NH4Cl solution was added followed by extraction with EtOAc (3*200 mL).
The combined organic layers were dried (Na2SO4) and evaporated in vacuo to obtain i (18.0 g, 90percent).
1H NMR (DMSO-d6, 400 MHz): δ 8.30 (d, J=4.8 Hz, 1H), 7.54 (s, 1H), 7.35 (d, J=4.8 Hz, 1H), 5.55 (t, J=6.0 Hz, 1H) and 4.53-4.54 (d, J=5.6 Hz, 2H).
Reference: [1] Patent: US2013/252938, 2013, A1, . Location in patent: Paragraph 0506
[2] Patent: WO2009/77990, 2009, A1, . Location in patent: Page/Page column 83-84
  • 4
  • [ 26156-48-9 ]
  • [ 118289-16-0 ]
Reference: [1] Journal of Medicinal Chemistry, 1997, vol. 40, # 18, p. 2866 - 2875
  • 5
  • [ 695-34-1 ]
  • [ 118289-16-0 ]
Reference: [1] Chemical and Pharmaceutical Bulletin, 1990, vol. 38, # 9, p. 2446 - 2458
  • 6
  • [ 4926-28-7 ]
  • [ 118289-16-0 ]
Reference: [1] Chemical and Pharmaceutical Bulletin, 1990, vol. 38, # 9, p. 2446 - 2458
  • 7
  • [ 118289-16-0 ]
  • [ 83004-14-2 ]
YieldReaction ConditionsOperation in experiment
50% With phosphorus tribromide In toluene at 0 - 100℃; for 0.5 h; Inert atmosphere To the solution of i (18 g, 95.74 mmol) in toluene (180 mL) was added dropwise phosphorous tribromide (13.4 mL, 143.62 mmol) at 0° C. under inert atmosphere.
The mixture was heated at 100° C. for 30 min.
The reaction was cooled at 0° C. and NaHCO3 solution added followed by extraction with EtOAc (2*500 mL).
The combined organic layer were dried (Na2SO4) and evaporated in vacuo.
The residue was purified over silica eluting with 15percent EtOAc:Hexane to obtain ii (12.0 g, 50percent).
1H NMR (CDCl3, 400 MHz): δ 8.35 (d, J=4.8 Hz, 1H), 7.51 (s, 1H), 7.26 (d, J=6.0 Hz, 1H) and 4.34 (s, 2H). MS 251.80 [M+H]+.
Reference: [1] Patent: US2013/252938, 2013, A1, . Location in patent: Paragraph 0507
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 118289-16-0 ]

Bromides

Chemical Structure| 1055073-69-2

[ 1055073-69-2 ]

2-(2-Bromopyridin-4-yl)propan-2-ol

Similarity: 0.85

Chemical Structure| 4926-28-7

[ 4926-28-7 ]

2-Bromo-4-methylpyridine

Similarity: 0.84

Chemical Structure| 1086381-43-2

[ 1086381-43-2 ]

2-Bromo-4-isopropylpyridine

Similarity: 0.81

Chemical Structure| 83004-14-2

[ 83004-14-2 ]

2-Bromo-4-(bromomethyl)pyridine

Similarity: 0.80

Chemical Structure| 32938-44-6

[ 32938-44-6 ]

2-Bromo-4-(bromomethyl)pyridine hydrobromide

Similarity: 0.80

Alcohols

Chemical Structure| 1055073-69-2

[ 1055073-69-2 ]

2-(2-Bromopyridin-4-yl)propan-2-ol

Similarity: 0.85

Chemical Structure| 65737-59-9

[ 65737-59-9 ]

Pyridin-4-ylmethanol hydrobromide

Similarity: 0.82

Chemical Structure| 105250-16-6

[ 105250-16-6 ]

(2-Methylpyridin-4-yl)methanol

Similarity: 0.77

Chemical Structure| 1227601-75-3

[ 1227601-75-3 ]

(2-Bromo-3-fluoropyridin-4-yl)methanol

Similarity: 0.76

Chemical Structure| 38070-80-3

[ 38070-80-3 ]

Pyridine-3,4-diyldimethanol

Similarity: 0.74

Related Parent Nucleus of
[ 118289-16-0 ]

Pyridines

Chemical Structure| 1055073-69-2

[ 1055073-69-2 ]

2-(2-Bromopyridin-4-yl)propan-2-ol

Similarity: 0.85

Chemical Structure| 4926-28-7

[ 4926-28-7 ]

2-Bromo-4-methylpyridine

Similarity: 0.84

Chemical Structure| 65737-59-9

[ 65737-59-9 ]

Pyridin-4-ylmethanol hydrobromide

Similarity: 0.82

Chemical Structure| 1086381-43-2

[ 1086381-43-2 ]

2-Bromo-4-isopropylpyridine

Similarity: 0.81

Chemical Structure| 32938-44-6

[ 32938-44-6 ]

2-Bromo-4-(bromomethyl)pyridine hydrobromide

Similarity: 0.80